re: Ozempic maker Novo Nordisk surges past Tesla with market value of $566B

Yes, I understand.

I think maybe I poorly worded that, let me try it another way.

If we're going to say Z91.1 is a reason to justify pharmaceutical treatment at the expense of the healthcare system wouldn't it make more sense to allow those dollars to be spent on the compliant patients?

We're increasing the dollars spent on patients who don't want to what their primary care physician instructs them to do. Want to take ozempic and you're non compliant, okay...pay for it. Want to take ozempic and you're compliant, why do you need ozempic? Do the meds need asdjusting? Is your A1c in range? Are you on a statin?

The default here to increase spending on the non compliant is madness and is costing billions of dollars a year with no long term improvements because the issue isn't diabetes or weight loss, it's wasting too much money and resources on the non compliant who have zero desire to be compliant or accept the financial burdens of their non compliance.